HK1201850A1 - Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy - Google Patents
Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy Download PDFInfo
- Publication number
- HK1201850A1 HK1201850A1 HK15102275.5A HK15102275A HK1201850A1 HK 1201850 A1 HK1201850 A1 HK 1201850A1 HK 15102275 A HK15102275 A HK 15102275A HK 1201850 A1 HK1201850 A1 HK 1201850A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- peptides
- hydrochloride salt
- peptide
- immunotherapy
- combination
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201208293A GB201208293D0 (en) | 2012-05-11 | 2012-05-11 | Hydrochlorice salt of peptide |
| GB1208293.9 | 2012-05-11 | ||
| PCT/GB2013/051201 WO2013167897A1 (en) | 2012-05-11 | 2013-05-09 | Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1201850A1 true HK1201850A1 (en) | 2015-09-11 |
Family
ID=46396890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15102275.5A HK1201850A1 (en) | 2012-05-11 | 2013-05-09 | Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy |
Country Status (17)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201406569D0 (en) | 2014-04-11 | 2014-05-28 | Stabilitech Ltd | Vaccine compositions |
| GB201501017D0 (en) * | 2014-12-23 | 2015-03-04 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers |
| HUE056607T2 (hu) | 2014-12-23 | 2022-02-28 | Immatics Biotechnologies Gmbh | Új peptidek és peptidkombinációk, hepatocelluláris karcinóma (HCC) és más rákok elleni immunoterápiában történõ alkalmazásra |
| PT3388075T (pt) | 2015-03-27 | 2023-08-18 | Immatics Biotechnologies Gmbh | Novos péptidos e combinações de péptidos para uso em imunoterapia contra vários tumores |
| GB201505305D0 (en) | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
| GB2562241B (en) | 2017-05-08 | 2022-04-06 | Stabilitech Biopharma Ltd | Vaccine compositions |
| WO2021038431A1 (en) * | 2019-08-26 | 2021-03-04 | Auro Peptides Ltd | An improved process for the preparation of etelcalcetide hydrochloride |
| TWI792442B (zh) * | 2021-07-23 | 2023-02-11 | 建誼生技股份有限公司 | 依特卡肽鹽酸鹽之製造方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003047618A2 (en) | 2001-12-05 | 2003-06-12 | Circassia Limited | Immunotherapeutic methods and systems |
| AU2007207618B2 (en) * | 2006-01-18 | 2011-03-24 | Foresee Pharmaceuticals Co., Ltd. | Pharmaceutical compositions with enhanced stability |
| GB0710529D0 (en) | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
| DK2190473T3 (da) * | 2007-08-15 | 2013-03-25 | Circassia Ltd | Peptid med reduceret dimerdannelse |
| GB2455108A (en) * | 2007-11-28 | 2009-06-03 | Circassia Ltd | T-Cell dependent method for detecting non-allergic or intrinsic disorders |
| GB0821806D0 (en) | 2008-11-28 | 2009-01-07 | Circassia Ltd | Compositions with reduced dimer formation |
| CA2795047C (en) * | 2010-03-31 | 2019-04-09 | Stabilitech Ltd. | Stabilised liquid formulations |
-
2012
- 2012-05-11 GB GB201208293A patent/GB201208293D0/en not_active Ceased
-
2013
- 2013-05-09 GB GB201421491A patent/GB2517354A/en not_active Withdrawn
- 2013-05-09 CA CA 2873120 patent/CA2873120A1/en not_active Abandoned
- 2013-05-09 BR BR112014028130A patent/BR112014028130A2/pt not_active IP Right Cessation
- 2013-05-09 CN CN201380036507.6A patent/CN104428311B/zh not_active Expired - Fee Related
- 2013-05-09 AU AU2013257784A patent/AU2013257784A1/en not_active Abandoned
- 2013-05-09 JP JP2015510875A patent/JP5982562B2/ja not_active Expired - Fee Related
- 2013-05-09 WO PCT/GB2013/051201 patent/WO2013167897A1/en active Application Filing
- 2013-05-09 KR KR20147034734A patent/KR20150014955A/ko not_active Withdrawn
- 2013-05-09 US US14/400,052 patent/US9657061B2/en not_active Expired - Fee Related
- 2013-05-09 HK HK15102275.5A patent/HK1201850A1/xx unknown
- 2013-05-09 EA EA201492068A patent/EA201492068A1/ru unknown
- 2013-05-09 EP EP13722023.2A patent/EP2847209B8/en not_active Not-in-force
- 2013-05-09 MX MX2014013394A patent/MX2014013394A/es unknown
- 2013-05-09 SG SG11201407446TA patent/SG11201407446TA/en unknown
- 2013-05-09 IN IN9367DEN2014 patent/IN2014DN09367A/en unknown
-
2014
- 2014-10-29 IL IL235388A patent/IL235388A/en not_active IP Right Cessation
- 2014-11-12 ZA ZA2014/08290A patent/ZA201408290B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2847209A1 (en) | 2015-03-18 |
| GB2517354A (en) | 2015-02-18 |
| IL235388A (en) | 2016-06-30 |
| BR112014028130A2 (pt) | 2017-08-15 |
| JP5982562B2 (ja) | 2016-08-31 |
| MX2014013394A (es) | 2015-02-04 |
| KR20150014955A (ko) | 2015-02-09 |
| CN104428311B (zh) | 2019-11-01 |
| US20150110820A1 (en) | 2015-04-23 |
| JP2015517484A (ja) | 2015-06-22 |
| SG11201407446TA (en) | 2015-03-30 |
| WO2013167897A1 (en) | 2013-11-14 |
| IN2014DN09367A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | 2015-07-17 |
| GB201208293D0 (en) | 2012-06-20 |
| CA2873120A1 (en) | 2013-11-14 |
| EP2847209B1 (en) | 2020-08-05 |
| EP2847209B8 (en) | 2020-10-07 |
| ZA201408290B (en) | 2016-01-27 |
| EA201492068A1 (ru) | 2015-03-31 |
| US9657061B2 (en) | 2017-05-23 |
| CN104428311A (zh) | 2015-03-18 |
| AU2013257784A1 (en) | 2014-11-20 |
| GB201421491D0 (en) | 2015-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1201850A1 (en) | Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy | |
| WO2013000922A9 (en) | Ccr2 antagonist peptides | |
| PL2547692T3 (pl) | Pochodne peptydów, ich wytwarzanie i ich zastosowania | |
| ZA201308251B (en) | Amino acid sequence presenting fusion polypeptide and its use | |
| UA118167C2 (uk) | Пептид та його застосування | |
| GB201206559D0 (en) | Polypeptide | |
| IL228813A0 (en) | Amino acid sequences directed against a17-il, f17-il and/or f/a17-il and polypeptides containing them | |
| MX2020010399A (es) | 3-epimerasa. | |
| IL223285A0 (en) | Cell-penetrating peptides and uses therof | |
| HK1205746A1 (en) | Interleukin-10 polypeptide conjugates and their uses | |
| CN104540941A8 (zh) | 获得肽的方法 | |
| WO2010129895A3 (en) | Cd133 epitopes | |
| WO2013078217A3 (en) | Anti-microbial peptides and methods of use thereof | |
| NZ629843A (en) | Identification of channelrhodopsin-2 (chop2) mutations and methods of use | |
| EP2593595A4 (en) | NOVEL PEPTIDES AND USES THEREOF | |
| WO2015185758A3 (en) | Preparation comprising factor viii and von willebrand factor peptides | |
| JP2010265269A5 (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | ||
| NZ706884A (en) | Fc gamma receptor iib variants | |
| NZ629130A (en) | Tfpi inhibitors and methods of use | |
| EP4269562A3 (en) | Antigen binding molecules and methods of use thereof | |
| WO2011135222A3 (fr) | Utilisation de peptides comme transporteurs destines a l'internalisation de molecules d'interet dans des cellules cibles | |
| EP3263123A3 (en) | Shk-based pharmaceutical compositions and methods of manufacturing and using the same | |
| WO2011034659A3 (en) | Advantageous mu-opiate receptor peptide compounds | |
| WO2013156458A8 (en) | Reduction of formation of amidated amino acids in cell lines for protein expression | |
| IL225464A0 (en) | 2nd peptides, preparations containing them and their uses |